This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Clarissa had been suffering from severe depression (MDD) since she was 18 years old. After getting some positive results from therapy and medication, she soon became consumed by the painful side effects of the medication. In her desperation, Clarissa turned to Silicon Valley TMS Integrated Clinical Neurosciences that provides treatment for depression using the BrainsWay dTMS system.
Shortly after starting the treatment, Clarissa started to see results. After just a couple of sessions, she was already starting to feel some improvement. The sessions, lasting 20 minutes, were tolerable and nearly painless.
Depression is a condition that affects over 15 million Americans and an estimated 300 million individuals worldwide. Severe depression, or MDD (Major Depressive Disorder), is defined by long periods of sadness, a loss of interest in daily activities, as well as a decrease in energy, fatigue and overwhelming feelings of loneliness, appetite changes, irritability, sexual dysfunction, suicidal thoughts, and more. These physical and emotional symptoms that define depression are caused by a combination of genetic, environmental, and biological and psychological factors. Depression symptoms are wide-ranging and impact every aspect of one’s life, including behavior and mental state. Although so many people suffer from depression, proper treatment is still limited.
The human brain is one of the most complex organs in the human body. Its intricate neural connections and functions make it very challenging to study and understand. However, within the last few decades, neuroscientists and psychiatrists have made great strides toward a better understanding of the human brain. Companies like BrainsWay are at the forefront of these advances. BrainsWay’s flagship technology – Deep Transcranial Magnetic Stimulation (dTMS) gives individuals with depression a more appealing option to help combat the debilitating symptoms. TMS uses a magnetic field to stimulate neurons in the brain in a noninvasive manner, helping to relieve the symptoms of depression. Since receiving FDA clearance in 2008, BrainsWay has been providing life-changing treatment for people with treatment-resistant depression.
BrainsWay’s dTMS is a unique and well-tolerated outpatient procedure, that has proven to reach deeper brain regions than all other TMS products currently on the market. BrainsWay’s patented H-coil allows for deeper and broader stimulation, increasing its accuracy and efficacy. The magnetic field formed by the H-Coil also dissipates slowly, leading to better clinical results. The BrainsWay helmet design is easier for physicians to operate and more convenient and comfortable for individuals receiving the treatment. Instead of lying down to receive treatment, the mobile helmet-like device allows the individual receiving treatment to sit up and watch TV or read.
dTMS has transformed Clarissa’s life, and she is just one of the thousands of people whose lives have changed for the better with BrainsWay’s dTMS.